Glycopeptide: Difference between revisions
Ostermayer (talk | contribs) No edit summary |
Ostermayer (talk | contribs) |
||
| Line 1: | Line 1: | ||
==Adverse Effects== | ==Adverse Effects== | ||
* '''Red Man Syndrome''': Flushing, rash, itching, hypotension during IV infusion; prevent with slow infusion. | * '''[[Red Man Syndrome]]''': Flushing, rash, itching, hypotension during IV infusion; prevent with slow infusion. | ||
* '''Nephrotoxicity''': Kidney damage, especially with high doses or concurrent nephrotoxic drugs; monitor renal function. | * '''Nephrotoxicity''': Kidney damage, especially with high doses or concurrent nephrotoxic drugs; monitor renal function. | ||
* '''Ototoxicity''': Hearing loss or tinnitus, more common with high levels or prolonged use. | * '''Ototoxicity''': Hearing loss or tinnitus, more common with high levels or prolonged use. | ||
Latest revision as of 13:08, 30 August 2025
Adverse Effects
- Red Man Syndrome: Flushing, rash, itching, hypotension during IV infusion; prevent with slow infusion.
- Nephrotoxicity: Kidney damage, especially with high doses or concurrent nephrotoxic drugs; monitor renal function.
- Ototoxicity: Hearing loss or tinnitus, more common with high levels or prolonged use.
- Hematologic Effects: Neutropenia, thrombocytopenia, or anemia; usually reversible.
- Hypersensitivity Reactions: Rash, fever, or severe reactions like Stevens-Johnson syndrome.
- Gastrointestinal Issues: Nausea, vomiting, diarrhea (more with oral use).
- Other: Phlebitis, elevated liver enzymes, or superinfections.
List of Glycopeptides
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||